SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 213 filers reported holding SEATTLE GENETICS INC in Q1 2014. The put-call ratio across all filers is 2.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,659,001,000 | +20.3% | 26,392 | +1.0% | 1.02% | +17.0% |
| Q4 2016 | $1,378,775,000 | -2.2% | 26,128 | +0.1% | 0.87% | +1.4% |
| Q3 2016 | $1,410,039,000 | +30.9% | 26,107 | -2.1% | 0.86% | +30.0% |
| Q2 2016 | $1,077,209,000 | +10.5% | 26,657 | -4.1% | 0.66% | +20.8% |
| Q1 2016 | $975,046,000 | -18.3% | 27,787 | +4.5% | 0.55% | -20.0% |
| Q4 2015 | $1,192,910,000 | +34.5% | 26,580 | +15.6% | 0.69% | +23.2% |
| Q3 2015 | $886,996,000 | -3.5% | 23,003 | +21.1% | 0.56% | +6.7% |
| Q2 2015 | $919,213,000 | +119.4% | 18,992 | +60.2% | 0.52% | +125.0% |
| Q1 2015 | $419,039,000 | 0.0% | 11,854 | 0.0% | 0.23% | 0.0% |
| Q1 2014 | $419,039,000 | – | 11,854 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |